Salah Eddine El Herrag

Ph.D. student in Cell Biology and Pathology

Nivolumab efficacy as cancer therapy: a meta-analysis of phase III randomized clinical trials


Conference paper


Salah Eddine El Herrag, Meghit Boumediene Khaled, Soraya Moulessehoul
13th Oncology Meeting Rabah Ferhat, Arab Medical Association Against Cancer (AMAAC) and Algerian Society Of Training & Research In Oncology (SAFRO), Hotel Sheraton Club des Pins, Alger, 2021 Dec 16

Congress Book
Cite

Cite

APA   Click to copy
Herrag, S. E. E., Khaled, M. B., & Moulessehoul, S. (2021). Nivolumab efficacy as cancer therapy: a meta-analysis of phase III randomized clinical trials. Hotel Sheraton Club des Pins, Alger: Arab Medical Association Against Cancer (AMAAC) and Algerian Society Of Training & Research In Oncology (SAFRO).


Chicago/Turabian   Click to copy
Herrag, Salah Eddine El, Meghit Boumediene Khaled, and Soraya Moulessehoul. “Nivolumab Efficacy as Cancer Therapy: a Meta-Analysis of Phase III Randomized Clinical Trials.” 13th Oncology Meeting Rabah Ferhat. Hotel Sheraton Club des Pins, Alger: Arab Medical Association Against Cancer (AMAAC) and Algerian Society Of Training & Research In Oncology (SAFRO), 2021.


MLA   Click to copy
Herrag, Salah Eddine El, et al. Nivolumab Efficacy as Cancer Therapy: a Meta-Analysis of Phase III Randomized Clinical Trials. Arab Medical Association Against Cancer (AMAAC) and Algerian Society Of Training & Research In Oncology (SAFRO), 2021.


BibTeX   Click to copy

@inproceedings{salah2021a,
  title = {Nivolumab efficacy as cancer therapy: a meta-analysis of phase III randomized clinical trials},
  year = {2021},
  month = dec,
  day = {16},
  address = {Hotel Sheraton Club des Pins, Alger},
  organization = {Arab Medical Association Against Cancer (AMAAC) and Algerian Society Of Training & Research In Oncology (SAFRO)},
  series = {13th Oncology Meeting Rabah Ferhat},
  author = {Herrag, Salah Eddine El and Khaled, Meghit Boumediene and Moulessehoul, Soraya},
  month_numeric = {12}
}

Poster

Share



Follow this website


You need to create an Owlstown account to follow this website.


Sign up

Already an Owlstown member?

Log in